CD69 was known as an early activation marker antigen of lymphocytes, had a crucial role in the pathogenesis of arthritis and allergic airway inflammation and could be a possible therapeutic target for arthritis and asthma in human patients (76). This evidence concerns the gene CD69 and arthritic joint disease.